Cullinan Therapeutics Inc
(CGEM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -169,166 | -118,556 | -48,501 | -167,575 | -119,928 |
| Depreciation Amortization | 232 | 153 | 76 | 306 | 229 |
| Accounts payable and accrued liabilities | 40 | 779 | 1,720 | -812 | -378 |
| Other Working Capital | 7,940 | 2,395 | -1,793 | -389 | -5,210 |
| Other Operating Activity | 23,313 | 14,465 | 5,343 | 23,167 | 16,610 |
| Operating Cash Flow | $-137,641 | $-100,764 | $-43,155 | $-145,303 | $-108,677 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -38 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -216,936 | -204,366 | -125,840 | -721,131 | -553,095 |
| Sale Of Investment | 374,572 | 294,572 | 162,645 | 584,817 | 400,817 |
| Investing Cash Flow | $157,598 | $90,206 | $36,805 | $-136,314 | $-152,278 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 373 | 373 | N/A | 270,636 | 269,054 |
| Other Financing Activity | 0 | 0 | 0 | -4,448 | -4,448 |
| Financing Cash Flow | $373 | $373 | $N/A | $266,188 | $264,606 |
| Beginning Cash Position | 83,005 | 83,005 | 83,005 | 98,434 | 98,434 |
| End Cash Position | 103,335 | 72,820 | 76,655 | 83,005 | 102,085 |
| Net Cash Flow | $20,330 | $-10,185 | $-6,350 | $-15,429 | $3,651 |
| Free Cash Flow | |||||
| Operating Cash Flow | -137,641 | -100,764 | -43,155 | -145,303 | -108,677 |
| Capital Expenditure | -38 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -137,679 | -100,764 | -43,155 | -145,303 | -108,677 |